Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The risk of developing depression when suffering from neurological diseases.
CCL2 induction by 1,25(OH)2D3 in dendritic cells from healthy donors and multiple sclerosis patients.
Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Promoting return of function in multiple sclerosis: An integrated approach.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
A questionnaire survey comparing the educational priorities of patients and medical students in the management of multiple sclerosis.
The most fulminant course of the Marburg variant of multiple sclerosis-autopsy findings.
Multiple sclerosis drugs: how much bang for the buck?
Effect of comorbidity on mortality in multiple sclerosis.
Abnormal adaptation over time of motor network recruitment in multiple sclerosis patients with fatigue.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
Differential loss of KIR4.1 immunoreactivity in multiple sclerosis lesions.
Immunosuppressive monoclonal antibody to CD64 from patients with long-term stable multiple sclerosis.
Progressive multifocal leukoencephalopathy in patients with multiple sclerosis.
Mimics and rare presentations of pediatric demyelination.
Transanal irrigation for bowel symptoms in patients with multiple sclerosis.
Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.
Objective duplex ultrasound evaluation of the extracranial circulation in multiple sclerosis patients undergoing venoplasty of internal jugular vein stenoses: A pilot study.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Pages
« first
‹ previous
…
347
348
349
350
351
352
353
354
355
…
next ›
last »